Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 12/20 | 0.55 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beauvericin SCHEMBL22510041 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| Beauvericin SCHEMBL29355 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| Beauvericin SCHEMBL16218239 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL30932793 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL29519838 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL17520706 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| SCHEMBL17520687 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| SCHEMBL17520688 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| Beauvericin A SCHEMBL30278897 | 0.92 | ABCB1 (0.49) | ABCB1HDAC6MMP1MMP3MMP9 | |
| SCHEMBL30278900 | 0.92 | ABCB1 (0.49) | ABCB1HDAC6MMP1MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118045028-A | Deep nourishing hair conditioner and preparation method thereof | 广州发妍化妆品制造有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-110286178-B | High-throughput analysis method for detecting 22 mycotoxins in health food oral liquid | 弘正道（中国）中药研究有限公司 | 2022-11-08 | — | — | CN | disclosed |
| US-20210338758-A1 | USE OF AT LEAST ONE GLYCYRRHIZA PLANT-BASED PREPARATION, AN ANTIDOTE MADE FROM SAME, AND THE USE OF SAID ANTIDOTE | ERBER AKTIENGESELLSCHAFT (AT) | 2021-11-04 | — | — | US | disclosed |
| US-20200268819-A1 | USE OF AT LEAST ONE GLYCYRRHIZA PLANT-BASED PREPARATION, AN ANTIDOTE MADE FROM SAME, AND THE USE OF SAID ANTIDOTE | ERBER AKTIENGESELLSCHAFT (AT) | 2020-08-27 | — | — | US | disclosed |
| CN-110286178-A | The high throughput analysis method of 22 kinds of mycotoxins in a kind of detection health-care food oral liquid | 弘正道（中国）中药研究有限公司 | 2019-09-27 | — | — | CN | disclosed |
| CN-108245550-A | At least one Radix Glycyrrhizae galenical, antidote and application thereof | 爱尔伯股份公司 | 2018-07-06 | — | — | CN | disclosed |
| WO-2018121881-A1 | USE OF AT LEAST ONE GLYCYRRHIZA PLANT-BASED PREPARATION, AN ANTIDOTE MADE FROM SAME, AND THE USE OF SAID ANTIDOTE | ERBER AKTIENGESELLSCHAFT (AT) | 2018-07-05 | — | — | WO | disclosed |
| EP-3342416-A1 | USE OF AT LEAST ONE GLYCYRRHIZA PLANT PREPARATION, AN ANTIDOTE CONTAINING SAME AND USE OF THE ANTIDOTE | Erber Aktiengesellschaft (AT) | 2018-07-04 | — | — | EP | disclosed |
| CN-1968685-A | Screening of Interactive drugs | LIXIN ZHANG (US) | 2007-05-23 | — | — | CN | disclosed |
| WO-2005051303-A2 | SCREENING FOR SYNERGISTIC COMPOUNDS | ZHANG LIXIN (US) | 2005-06-09 | — | — | WO | disclosed |